Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabine Kinloch

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
AIDS (London, England)|December 22, 2023
Rapid antiretroviral therapy in primary HIV-1 infection enhances immune recoveryJohn Patrick Thornhill, Julie Fox, Genevieve Elizabeth Martin, et al.
JCI Insight|February 22, 2024
IL-15 reprogramming compensates for NK cell mitochondrial dysfunction in HIV-1 infectionElia Moreno-Cubero, Aljawharah Alrubayyi, Stefan Balint, et al.
Open Forum Infectious Diseases|November 28, 2015
Aviremia 10 Years Postdiscontinuation of Antiretroviral Therapy Initiated During Primary Human Immunodeficiency Virus-1 Infection and Association With Gag-Specific T-Cell ResponsesSabine Kinloch-de Loes, Lucy Dorrell, Hongbing Yang, et al.
Plos One|April 13, 2011
Early and prolonged antiretroviral therapy is associated with an HIV-1-specific T-cell profile comparable to that of long-term non-progressorsCristina Cellerai, Alexandre Harari, Hans Stauss, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
Preserved CD4 <sup>+</sup> T cell helper function and coordinated antiviral immunity in people with HBV/HIV co-infection on long-term therapyAljawharah Alrubayyi, Anucha Preechanukul, Yinru Zhang, et al.
The Lancet. HIV|June 4, 2021
Failure to seroconvert after two doses of BNT162b2 SARS-CoV-2 vaccine in a patient with uncontrolled HIVEmma Touizer, Aljawharah Alrubayyi, Chloe Rees-Spear, et al.
Plos Pathogens|July 15, 2016
Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 InfectionMatthias Hoffmann, Nikos Pantazis, Genevieve E Martin, et al.
Journal of Virus Eradication|July 11, 2024
Impact of interrupting antiretroviral therapy started during primary HIV-1 infection on plasma neurofilament light chain protein, a marker of neuronal injury: The SPARTAC trialJasmini Alagaratnam, Wolfgang Stöhr, Elizabeth Hamlyn, et al.
Elife|September 14, 2014
HIV-1 DNA predicts disease progression and post-treatment virological controlJames P Williams, Jacob Hurst, Wolfgang Stöhr, et al.
The New England Journal of Medicine|January 18, 2013
Short-course antiretroviral therapy in primary HIV infection, Sarah Fidler, Kholoud Porter, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
AIDS (London, England)|December 22, 2023
Rapid antiretroviral therapy in primary HIV-1 infection enhances immune recoveryJohn Patrick Thornhill, Julie Fox, Genevieve Elizabeth Martin, et al.
JCI Insight|February 22, 2024
IL-15 reprogramming compensates for NK cell mitochondrial dysfunction in HIV-1 infectionElia Moreno-Cubero, Aljawharah Alrubayyi, Stefan Balint, et al.
Open Forum Infectious Diseases|November 28, 2015
Aviremia 10 Years Postdiscontinuation of Antiretroviral Therapy Initiated During Primary Human Immunodeficiency Virus-1 Infection and Association With Gag-Specific T-Cell ResponsesSabine Kinloch-de Loes, Lucy Dorrell, Hongbing Yang, et al.
Plos One|April 13, 2011
Early and prolonged antiretroviral therapy is associated with an HIV-1-specific T-cell profile comparable to that of long-term non-progressorsCristina Cellerai, Alexandre Harari, Hans Stauss, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
Preserved CD4 <sup>+</sup> T cell helper function and coordinated antiviral immunity in people with HBV/HIV co-infection on long-term therapyAljawharah Alrubayyi, Anucha Preechanukul, Yinru Zhang, et al.
The Lancet. HIV|June 4, 2021
Failure to seroconvert after two doses of BNT162b2 SARS-CoV-2 vaccine in a patient with uncontrolled HIVEmma Touizer, Aljawharah Alrubayyi, Chloe Rees-Spear, et al.
Plos Pathogens|July 15, 2016
Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 InfectionMatthias Hoffmann, Nikos Pantazis, Genevieve E Martin, et al.
Journal of Virus Eradication|July 11, 2024
Impact of interrupting antiretroviral therapy started during primary HIV-1 infection on plasma neurofilament light chain protein, a marker of neuronal injury: The SPARTAC trialJasmini Alagaratnam, Wolfgang Stöhr, Elizabeth Hamlyn, et al.
Elife|September 14, 2014
HIV-1 DNA predicts disease progression and post-treatment virological controlJames P Williams, Jacob Hurst, Wolfgang Stöhr, et al.
The New England Journal of Medicine|January 18, 2013
Short-course antiretroviral therapy in primary HIV infection, Sarah Fidler, Kholoud Porter, et al.
Pageof 7